Literature DB >> 9747929

Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective.

V Silani1, E J Kasarskis, N Yanagisawa.   

Abstract

Although respiratory failure is the primary cause of death in patients with amyotrophic lateral sclerosis (ALS), the management of nutritional status is important to enhancing the quality of life and optimising the timing of interventive techniques. Progressively weakening muscles impair the patient's ability to eat, and nearly all patients with ALS develop severe dysphagia. If nutritional support is not provided, food and fluid consumption may be greatly restricted, leading to weight loss and malnutrition. This may be compounded by impaired respiratory functions, which place increased energy demands on the patient. This paper describes the nutritional needs of ALS patients from a worldwide and cross-cultural perspective. In particular, the differences between a paternalistic and a patient-centred approach to treatment are addressed. The need for further study into the nutritional status of ALS patients and the issue of parenteral and enteral nutritional therapy, particularly percutaneous endoscopic gastrostomy, are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9747929     DOI: 10.1007/pl00014805

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

Review 1.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

2.  Management of symptoms in amyotrophic lateral sclerosis.

Authors:  Lisa S Thibodeaux; Amparo Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 3.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

4.  Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats.

Authors:  Susan E Smittkamp; Heather N Spalding; Jordan W Brown; Anisha A Gupte; Jie Chen; Hiroshi Nishimune; Paige C Geiger; John A Stanford
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

Review 5.  Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Hans Dieter Katzberg; Michael Benatar
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

6.  Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis.

Authors:  Edward J Kasarskis; Marta S Mendiondo; Dwight E Matthews; Hiroshi Mitsumoto; Rup Tandan; Zachary Simmons; Mark B Bromberg; Richard J Kryscio
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

7.  Time-course and characterization of orolingual motor deficits in B6SJL-Tg(SOD1-G93A)1Gur/J mice.

Authors:  S E Smittkamp; J W Brown; J A Stanford
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

8.  An animal model of oral dysphagia in amyotrophic lateral sclerosis.

Authors:  Teresa E Lever; Ambre Gorsek; Kathleen T Cox; Kevin F O'Brien; Norman F Capra; Monica S Hough; Alexander K Murashov
Journal:  Dysphagia       Date:  2008-12-24       Impact factor: 3.438

Review 9.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

10.  Hypermetabolism in ALS patients: an early and persistent phenomenon.

Authors:  C Bouteloup; J-C Desport; P Clavelou; N Guy; H Derumeaux-Burel; A Ferrier; P Couratier
Journal:  J Neurol       Date:  2009-03-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.